[Form 4] MYRIAD GENETICS INC Insider Trading Activity

Rhea-AI Filing Summary

Phanstiel S. Louise reported acquisition or exercise transactions in this Form 4 filing.

Myriad Genetics Inc. director S. Louise Phanstiel received an equity award of 59,701 restricted stock units (RSUs). The award was granted under the company’s 2026 Employee, Director and Consultant Equity Incentive Plan at no cash cost to the director.

Each RSU represents a contingent right to receive one share of Myriad Genetics common stock and will vest upon the earlier of the first anniversary of the grant date or the next annual meeting of stockholders following the grant. After this grant, Phanstiel directly holds 341,652 shares of common stock, reflecting her updated ownership position including the new award.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Phanstiel S. Louise

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	59,701	$0.00	--

Holdings After Transaction: Common Stock — 341,652 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 59,701 units Grant price per unit: $0.00 Shares owned after grant: 341,652 shares +1 more

4 metrics

RSUs granted 59,701 units Restricted stock unit award to director on 2026-06-04

Grant price per unit $0.00 RSU award issued at no cash cost

Shares owned after grant 341,652 shares Director’s direct holdings following RSU award

Vesting schedule Earlier of 1 year or next annual meeting RSU vesting terms tied to grant date or stockholder meeting

Key Terms

restricted stock units, contingent right, Equity Incentive Plan, vests

4 terms

restricted stock units financial

"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock"

Equity Incentive Plan financial

"granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

vests financial

"and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Phanstiel S. Louise

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UTAH 84116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		59,701(1)	A	$0	341,652	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

Remarks:

	By: Justin Hunter For: S. Louise Phanstiel	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Myriad Genetics (MYGN) report for S. Louise Phanstiel?

Myriad Genetics reported that director S. Louise Phanstiel received a grant of 59,701 restricted stock units. These units were awarded at no cash cost under the 2026 Employee, Director and Consultant Equity Incentive Plan as part of her equity-based compensation.

How many Myriad Genetics (MYGN) shares does S. Louise Phanstiel hold after this Form 4 transaction?

Following the equity award, S. Louise Phanstiel directly holds 341,652 shares of Myriad Genetics common stock. This figure reflects her updated ownership position after receiving 59,701 restricted stock units that will convert into shares upon vesting.

What are the vesting terms of the 59,701 restricted stock units granted by Myriad Genetics (MYGN)?

The 59,701 restricted stock units vest upon the earlier of the first anniversary of the grant date or the next annual meeting of stockholders. Each vested unit will deliver one share of Myriad Genetics common stock to S. Louise Phanstiel.

Under which plan were the Myriad Genetics (MYGN) restricted stock units granted to S. Louise Phanstiel?

The restricted stock units were granted under Myriad Genetics’ 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. This plan provides equity-based awards, such as RSUs, to employees, directors, and consultants to align their interests with shareholders.

Did S. Louise Phanstiel buy or sell Myriad Genetics (MYGN) shares in this Form 4 filing?

The Form 4 shows an acquisition through a grant of 59,701 restricted stock units, not an open-market buy or sale. This is a compensation-related award at a stated price of $0.00 per unit, rather than a cash purchase or sale transaction.